Skip to content

SiriusPoint SPNT Payments to Acquire Debt Securities, Available-for-Sale

Payments to Acquire Debt Securities, Available-for-Sale at other companies

American International Group logo
American International GroupAIG
$7.06B-11.2%
ESN
Essent GroupESNT
$257.43M-26.4%
W.R. Berkley logo
W.R. BerkleyWRB
Ally Financial logo
Ally FinancialALLY

Other financials

Income statement

See full
Revenue$774.6M+6.5%
Net income$102.2M+65.9%
EPS (diluted)$0.82+67.3%

Balance sheet

See full
Cash & equivalents$1.0B+9.2%
Total debt$702.9M+2.2%
Total equity$2.3B+13.7%
Total assets$12.5B+1.6%

Cash flow

See full
Operating cash flow$141.9M+260%

Valuation

See full
Market cap$2.78B+25.6%
Enterprise value$2.47B+25.1%
P/E5.6×-6.5×
P/S0.9×0.0×

Profitability

See full
Net margin15.4%+8.4pp

Returns & leverage

See full
Return on equity23.1%+15.2pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by SiriusPoint in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: SiriusPoint’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SiriusPoint's payments to acquire debt securities, available-for-sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SiriusPoint's payments to acquire debt securities, available-for-sale?
SiriusPoint (SPNT) reported payments to acquire debt securities, available-for-sale of $274.2M in Q1 2026.
How has SiriusPoint's payments to acquire debt securities, available-for-sale changed year-over-year?
SiriusPoint's payments to acquire debt securities, available-for-sale decreased by 43.7% year-over-year, from $487.2M to $274.2M.
What is the long-term trend for SiriusPoint's payments to acquire debt securities, available-for-sale?
Over 2 years (2022 to 2025), SiriusPoint's payments to acquire debt securities, available-for-sale has grown at a -10.4% compound annual growth rate (CAGR), from $2.81B to $2.25B.